Cardiology · Congenital Heart Disease
The facts most likely to be tested
A Patent Foramen Ovale (PFO) results from the failure of the septum primum and septum secundum to fuse after birth.
The primary clinical significance of a PFO is its role as a potential conduit for paradoxical embolism from the venous circulation to the arterial system.
Patients with a PFO are at an increased risk for cryptogenic stroke, particularly in younger individuals without traditional cardiovascular risk factors.
The gold standard for diagnosing a PFO is a transesophageal echocardiogram (TEE) with a bubble study using agitated saline.
A positive bubble study is defined by the appearance of microbubbles in the left atrium within three cardiac cycles of opacification of the right atrium.
The Valsalva maneuver increases right-sided heart pressure, facilitating the right-to-left shunting of blood across the PFO.
Percutaneous device closure is indicated for patients under 60 years old with a cryptogenic stroke and a high-risk PFO anatomy, such as an atrial septal aneurysm.
Vignette unlocked
A 32-year-old male presents to the emergency department with sudden onset of right-sided hemiparesis and expressive aphasia. He has no history of hypertension, diabetes, or hyperlipidemia, and his EKG shows normal sinus rhythm. A carotid ultrasound is unremarkable, and a CT angiogram shows no large vessel occlusion. A transthoracic echocardiogram is performed, which is negative for thrombus, but a subsequent bubble study reveals the appearance of microbubbles in the left atrium shortly after the release of a Valsalva maneuver.
What is the most likely underlying mechanism for this patient's presentation?
Paradoxical embolism via a Patent Foramen Ovale (PFO)
The patient's presentation of a cryptogenic stroke in a young adult, combined with the positive bubble study during a Valsalva maneuver, is classic for a PFO allowing a venous thrombus to bypass the pulmonary filter and enter the systemic circulation.
Full handout
High yield triage
Etiology / Epidemiology
Present in 25% of the general population; failure of the septum primum and septum secundum to fuse post-birth.
Clinical Manifestations
Often asymptomatic; classic presentation is cryptogenic stroke in a patient <60 years old.
Diagnosis
Gold standard is bubble study (contrast-enhanced TEE) showing microbubbles in the left atrium within 3 cardiac cycles.
Treatment
First-line is antiplatelet therapy (aspirin); avoid anticoagulation unless indicated for other conditions.
Prognosis
Low risk of recurrence with medical management; percutaneous closure reserved for high-risk recurrent events.
Full handout
Epidemiology & Etiology
A PFO is a remnant of fetal circulation where the foramen ovale fails to close. It is found in approximately one-quarter of healthy adults. It is not a true septal defect but a valvular flap that remains patent.
Pertinent Anatomy
The PFO is located at the level of the fossa ovalis in the interatrial septum. It functions as a potential conduit for right-to-left shunting when right atrial pressure exceeds left atrial pressure.
Pathophysiology
Under normal conditions, left atrial pressure is higher, keeping the flap closed. Transient increases in right-sided pressure (e.g., Valsalva maneuver, coughing) can open the flap. This allows venous emboli to bypass pulmonary filtration, leading to paradoxical embolism.
Clinical Manifestations
Most patients are asymptomatic. The primary clinical concern is cryptogenic stroke or transient ischemic attack in young patients. Red flags include sudden neurological deficits following physical strain or platypnea-orthodeoxia syndrome in rare cases.
Diagnosis
The bubble study performed via transesophageal echocardiogram (TEE) is the gold standard. A positive result is defined by the appearance of microbubbles in the left atrium within 3 cardiac cycles after opacification of the right atrium.
Treatment
Initial management for PFO-associated stroke is antiplatelet therapy (e.g., aspirin). Anticoagulation is not superior to antiplatelets for PFO alone. Percutaneous device closure is indicated for patients <60 with a history of cryptogenic stroke and high-risk anatomical features.
Prognosis
The risk of recurrent stroke is low with medical therapy. Percutaneous closure significantly reduces the risk of recurrent stroke compared to medical therapy alone in highly selected patients.
Differential Diagnosis
Atrial Septal Defect: Fixed split S2 and left-to-right shunt
Paradoxical Embolism: Requires DVT or venous source
Atrial Fibrillation: Irregularly irregular rhythm on ECG
Hypercoagulable State: Positive Factor V Leiden or protein C/S deficiency
Carotid Artery Stenosis: Bruit on auscultation or plaque on ultrasound